Literature DB >> 22338300

An inquiry on pain management in the emergency department of training hospitals.

S Lemoyne1, P De Paepe, C Vankeirsbilck, W Buylaert.   

Abstract

INTRODUCTION: Improving pain management in the ED might be attained by adequate teaching of medical students. We assessed the skills in pain treatment of ED physicians who teach the students.
METHODS: All physicians working in an ED who provide elective training to undergraduate medical students from the Ghent University were asked to complete a questionnaire consisting of vignette patient cases concerning acute pain management of abdominal colic pain, and non-traumatic abdominal pain.
RESULTS: Thirty two physicians completed the cases. In the renal colic case 91% of the respondents proposed a NSAID as first line treatment. Butylhyoscine was still suggested by 18%. After initial failure of analgesia 31% administered a strong opioid. In biliary colic pain NSAIDs and butylhyoscine were proposed as first line analgesics by 59% and 31% respectively. In second line, butylhyoscine would be given by 22%. The patient case with right fossa abdominal pain would initially be treated with acetaminophen by 81%. Thirteen % of the respondents would not give further analgesia if the first line treatment was insufficient.
CONCLUSION: Our results indicate that adherence by teachers to evidence based guidelines of acute pain management is insufficient. Therefore improving knowledge and skills in pain management of the teachers should receive more attention.

Entities:  

Mesh:

Year:  2011        PMID: 22338300     DOI: 10.2143/ACB.66.6.2062603

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  1 in total

1.  Factors influencing ambulance nurses' adherence to a national protocol ambulance care: an implementation study in the Netherlands.

Authors:  Remco H A Ebben; Lilian C M Vloet; Pierre M van Grunsven; Wim Breeman; Ben Goosselink; Rob A Lichtveld; Joke A J Mintjes-De Groot; Theo van Achterberg
Journal:  Eur J Emerg Med       Date:  2015-06       Impact factor: 2.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.